SweetValueLab
Write for us

Bristol-Myers Squibb Company — Financial Statements & Ratios

BMY
NYSEHealthcareDrug Manufacturers - GeneralCIK 0000014272bms.comAbout BMY
Last close · Oct 16, 202659.75−0.82 (−1.35%)
Market cap$122.1B

Key indicators

Revenue49.2BTTM+3.1% on a year earlier+11.5% a year, FY2018–FY2025
Fiscal yearFY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025TTMFY2026EFY2027EFY2028E
Growth
22.6B 26.1B+15.9%42.5B+62.6%46.4B+9.1%46.2B−0.5%45.0B−2.5%48.3B+7.3%48.2B−0.2%49.2B+3.1%49.9B 48.5B 41.0B
— 15.9% 62.6% 9.1% -0.5% -2.5% 7.3% -0.2% 3.1% 3.5% -2.8% -15.5%
$3.01 $2.01−33.2%-$3.99−298.5%$3.12+178.2%$2.95−5.4%$3.86+30.8%-$4.41−214.2%$3.46+178.5%$4.55+83.5%$6.32 $6.62 $5.41
Profitability
71.0% 69.1%−1.9 pt72.3%+3.2 pt— — — — — — · · ·
21.8% 13.2%−8.7 pt-21.2%−34.4 pt15.1%+36.3 pt13.7%−1.4 pt17.8%+4.1 pt-18.5%−36.4 pt14.6%+33.2 pt18.9%+8.3 pt· · ·
— — -23.8% 19.5%+43.3 pt20.4%+0.9 pt27.3%+6.9 pt-54.8%−82.0 pt38.2%+93.0 pt— · · ·
Cash
5.0B 7.2B+44.9%13.3B+83.9%15.2B+14.5%11.9B−21.6%12.7B+5.9%13.9B+10.2%12.8B−7.9%11.4B−21.5%· · ·
22.1% 27.7%+5.5 pt31.3%+3.6 pt32.8%+1.6 pt25.9%−7.0 pt28.1%+2.2 pt28.9%+0.8 pt26.7%−2.2 pt23.3%−7.3 pt· · ·
2.6B 2.7B+2.5%4.1B+52.1%4.4B+7.9%4.6B+5.4%4.7B+2.4%4.9B+2.5%5.0B+3.7%— · · ·
Balance sheet
— — 1.34x 1.24x−0.10x1.27x+0.03x1.35x+0.09x3.04x+1.69x2.44x−0.60x1.93x−0.89x· · ·
1.64B 1.71B+4.6%2.26B+31.9%2.25B−0.6%2.15B−4.4%2.08B−3.2%2.03B−2.5%2.04B+0.6%2.05B+0.5%· · ·

E = analyst consensus (revenue and EPS only). TTM = the twelve months to Jun 30, 2026: the last fiscal year, plus the quarters since, less the same quarters a year earlier. From the 10-K and the 10-Qs since, as accepted by the SEC; the shaded column is the latest period.